In today’s recent session, 1.71 million shares of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) have been traded, and its beta is 1.01. Most recently the company’s share price was $0.74, and it changed around $0.02 or 3.05% from the last close, which brings the market valuation of the company to $269.70M. LXRX at last check was trading at a discount to its 52-week high of $2.45, offering almost -231.08% off that amount. The share price’s 52-week low was $0.28, which indicates that the recent value has risen by an impressive 62.16% since then. We note from Lexicon Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 4.23 million shares, with the 3-month average coming to 13.30 million.
Lexicon Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended LXRX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) trade information
Instantly LXRX has been showing a green trend so far today with a performance of 3.05% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.7694 on recent trading dayincreased the stock’s daily price by 3.82%. The company’s shares are currently up 0.56% year-to-date, but still up 5.77% over the last five days. On the other hand, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) is 33.61% up in the 30-day period. We can see from the shorts that 38.83 million shares have been sold at a short interest cover period of 9.4 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 87.67% from its current value. Analyst projections state that LXRX is forecast to be at a low of $6 and a high of $6.
Lexicon Pharmaceuticals Inc earnings are expected to increase by 49.60% in 2025, but the outlook is positive 30.30% per year for the next five years.
LXRX Dividends
Lexicon Pharmaceuticals Inc’s next quarterly earnings report is expected to be released on 2025-May-13.
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.17% of Lexicon Pharmaceuticals Inc shares, and 74.93% of them are in the hands of institutional investors. The stock currently has a share float of 75.82%. Lexicon Pharmaceuticals Inc stock is held by 166.0 institutions, with ARTAL GROUP S.A. being the largest institutional investor. By 2024-06-30, it held 56.3318% of the shares, which is about 175.1 million shares worth $294.17 million.
FMR LLC, with 12.4462% or 38.69 million shares worth $64.99 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
